Financial Health Assessment: Anglo Scottish Biosolids Ltd

1. Financial Health Score: C+

Explanation: The patient is stable but exhibiting chronic symptoms of long-term value erosion. While not in immediate danger—net assets remain substantial at £7.15M and working capital is positive—the consistent decline in shareholders' funds from £12.26M (2017) to £7.78M (2025) represents a 36.5% deterioration over eight years. Recent vital signs show tentative improvement, but the underlying condition requires ongoing management.

2. Key Vital Signs

Blood Pressure Reading: Leverage Assessment

The company's debt-to-assets ratio has risen from 10.6% to 18.6%—still within healthy parameters but representing a meaningful shift. The doubling of long-term creditors from £894K to £1.91M is the primary driver and warrants closer examination.

3. Diagnosis

Chronic Condition: Long-term Value Erosion

The financial history reveals a patient that has been gradually losing financial mass over an extended period:

Net Assets Trajectory: - 2017: £12,254,173 (peak) - 2019: £10,849,761 - 2021: £9,219,279 - 2023: £8,610,163 - 2025: £7,151,104

This represents a 41.6% decline from the 2017 peak—a chronic condition that, while not immediately life-threatening, signals underlying business challenges.

Acute Observations

1. Goodwill Dependency (The Enlarged Heart) Intangible assets of £4.35M represent 42.3% of total assets. This goodwill, acquired in 2015 and amortised over 20 years, is being written down annually. While this is standard treatment, the heavy reliance on intangible assets means the balance sheet strength is partially illusory—if the underlying business underperforms, impairment could deliver a significant shock.

2. Capital Restructuring (Surgical Intervention) The £1.5M reduction in called-up share capital (from £9.28M to £7.78M) suggests a deliberate capital return or restructuring. This is a legitimate procedure but has reduced the equity buffer. Combined with accumulated losses of £629K, the equity position is more precarious than headline figures suggest.

3. Positive Vital Signs (Recovery Indicators) - Retained earnings improved by £248K—the first meaningful improvement in the accumulated losses position - Cash increased by 62%—suggesting stronger cash generation or improved working capital management - Tangible assets grew from £3.27M to £3.58M, indicating continued investment in the operational base - Current ratio remains robust at 1.91x

4. Long-term Liability Growth (Rising Blood Pressure) The more than doubling of creditors due after one year (from £894K to £1.91M) is the most concerning acute symptom. This could indicate: - New financing arrangements (potentially positive if funding growth) - Deferred consideration or obligations coming due - Increased borrowing to fund operations (potentially negative)

Without a profit & loss account (filed under small company exemptions), the root cause is difficult to diagnose with certainty.

Overall Clinical Picture

The company is a going concern with meaningful asset backing but a persistent underlying condition. It is not exhibiting signs of imminent insolvency—working capital is positive, cash is improving, and liabilities are manageable relative to assets. However, the long-term erosion of net worth and the growing long-term liabilities suggest the business model may be under pressure.

4. Recommendations

Immediate Actions (Urgent Care)

1. Investigate Long-term Liability Increase The doubling of long-term creditors requires immediate diagnosis. Request full details of the composition—what obligations are being deferred, what terms apply, and whether this represents normal financing or emerging distress?

2. Monitor Goodwill for Impairment With £4.35M in goodwill and net assets of £7.15M, any impairment would significantly impact the balance sheet. Annual impairment reviews should be rigorous and documented, particularly given the declining profitability trend evidenced by accumulated losses.

Medium-term Treatment (Rehabilitation Plan)

3. Restore Retained Earnings to Positive Territory The £629K accumulated loss represents a vulnerability. The business should prioritise profitability to rebuild this buffer. At the recent improvement rate of £248K per year, this could take approximately 2-3 years of consistent performance.

4. Cash Management Continuation The 62% cash improvement is encouraging. Maintain disciplined cash management and consider building reserves toward 3-6 months of operating costs as a liquidity buffer.

5. Review Capital Structure Given the capital reduction and accumulated losses, consider whether the current capital structure is optimal. A formal reduction of capital to eliminate accumulated losses (a "court-approved capital reduction") might provide a cleaner balance sheet, though this requires professional advice.

Long-term Wellness (Preventative Care)

6. Revenue and Profitability Review The absence of a P&L account makes it impossible to assess top-line health. The business should establish clear profitability targets and monitor gross and net margins monthly. The declining net assets suggest either persistent losses or significant dividend/withdrawal activity—either requires strategic attention.

7. Diversification of Asset Base With 42% of assets in intangibles, the balance sheet is concentrated. Investment in tangible productive assets (as seen in the 2025 figures) should continue to reduce this dependency.

8. Long-term Liability Management Develop a clear schedule for the £1.91M in long-term obligations. Ensure repayment terms are sustainable and that the business generates sufficient cash flow to service these commitments without compromising operational flexibility.

Prognosis

Cautiously Stable with Improving Trend

The patient has been in gradual decline for eight years but recent vital signs—improved cash, reduced accumulated losses, and continued tangible asset investment—suggest the condition may be stabilising. The key risk factors are the significant goodwill exposure and growing long-term liabilities. If the recent improvement in retained earnings continues and long-term liabilities are managed appropriately, the outlook is moderately positive. However, should profitability falter or require goodwill impairment, the financial position could deteriorate rapidly given the reduced equity buffer.